1500 Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 

CDC requests OMB approval for an 

estimated 3,126 total annualized burden 

hours. Participation is voluntary and 

there are no costs to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondent Form Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(hours) 

Persons Screened .......................................... Eligibility Screening Form English ................. 5,400 1 5/60 

Persons Screened .......................................... Eligibility Screening Form Spanish ................ 600 1 5/60 

Persons who give permission ......................... Model Project Consent Form English ............ 4,050 1 5/60 

Persons who give permission ......................... Model Project Permission Form Spanish ...... 450 1 5/60 

Eligible Participants ......................................... NEXUS Survey English .................................. 4,050 1 30/60 

Eligible Participants ......................................... NEXUS Survey Spanish ................................ 450 1 30/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2025–00159 Filed 1–7–25; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30 Day–25–1360] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘CryptoNet 

Case Report Form’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on October 

21, 2024 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street, NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

CryptoNet Case Report Form (OMB 

Control No. 0920–1360, Exp. 1/31/ 

2025)—Revision—National Center for 

Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The Waterborne Disease Prevention 

Branch (WDPB) in the Division of 

Foodborne, Waterborne, and 

Environmental Diseases (DFWED) works 

to prevent domestic and global waterrelated diseases. The WDPB is 

comprised of five teams, including the 

Domestic Waterborne Disease 

Epidemiology and Response (WDER) 

Team, which focuses on the prevention 

and control of waterborne-related 

diseases and outbreaks in the United 

States. One of the diseases included in 

the team’s work is cryptosporidiosis, an 

acute diarrheal disease caused by 

infection with Cryptosporidium 

parasites. 

The Case Surveillance Program is a 

subunit within the Domestic WDER 

Team that focus on the data collection 

and management activities of five 

waterborne diseases, including 

cryptosporidiosis, in the United States. 

The Case Surveillance Program’s current 

scope of work includes modernizing 

data collection and management, 

enabling data connections, and 

improving public data access to aid 

public health action. 

CryptoNet is the first molecular 

tracking system for Cryptosporidium in 

the United States. To meet the needs of 

the CryptoNet and Case Surveillance 

Program, and the needs of local officials, 

the CryptoNet case report form (CRF) 

was developed. The CRF includes a set 

of data elements that can be used to 

identify exposures trends in outbreakand non-outbreak-associated 

Cryptosporidium cases, to generate 

hypotheses about the sources of 

infection in clusters or outbreaks, and to 

identify strategies to prevent and control 

Cryptosporidium cases, clusters, or 

outbreaks. 

Data from the CRF will be used by 

federal, state, and local public health 

officials responsible for conducting 

interviews with reported cases of 

cryptosporidiosis in their jurisdiction in 

order to systemically assess core 

exposure elements and risk factors 

among cases of cryptosporidiosis. 

Collected data will be used by CDC staff 

to inform cryptosporidiosis sporadic 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 1501 

case, cluster, and outbreak prevention 

and control strategies. CRF data 

elements and the CRF were designed for 

administration via telephone interviews 

with individuals ill with 

cryptosporidiosis, or their designated 

proxy. 

CDC requests OMB approval for an 

estimated 125 annual burden hours. 

Providing information is voluntary, and 

there are no costs to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Individuals ill with cryptosporidiosis, or their 

designated proxy.

CryptoNet Case Report Form ........................ 500 1 15/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2025–00162 Filed 1–7–25; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–1357; Docket No. CDC–2024– 

0104] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled The Greater 

Access and Impact with NAT (GAIN) 

Study: Improving HIV Diagnosis, 

Linkage to Care, and Prevention 

Services with HIV Point-of-Care Nucleic 

Acid Tests (NATs). This study will 

identify facilitators and barriers with 

implementation of HIV point-of-care 

(POC) nucleic acid tests (NATs) in 

clinical settings, estimate the sensitivity 

and specificity of the HIV POC NAT, 

and assess the impact of the test in 

decreased time to receipt of HIV 

prevention and care. 

DATES: CDC must receive written 

comments on or before March 10, 2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0104 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

The Greater Access and Impact with 

NAT (GAIN) Study: Improving HIV 

Diagnosis, Linkage to Care, and 

Prevention Services with HIV Point-ofCare Nucleic Acid Tests (NATs) (OMB 

Control No. 0920–1357, Exp. 12/31/ 

2024)—Reinstatement—National Center 

for HIV, Viral Hepatitis, STD, and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC) 

Background and Brief Description 

HIV prevention and care services can 

be improved by the availability of Pointof-care (POC) HIV viral RNA testing in 

clinical settings. Viral RNA tests are the 

most sensitive HIV tests for the 

detection of early infection. The 

purpose of this data collection is to 

develop feasible and effective models to 

integrate HIV POC nucleic acid tests 

(NATs) in HIV prevention and treatment 

services. The HIV POC NAT can be used 

to test persons at high-risk of acquiring 

HIV infection to reduce the time 


lotter on DSK11XQN23PROD with NOTICES1